Literature DB >> 33107008

Improving Blood Pressure Management in Primary Care Patients with Chronic Kidney Disease: a Systematic Review of Interventions and Implementation Strategies.

Celia C Kamath1,2,3, Claudia C Dobler4, Rozalina G McCoy5,6,7, Michelle A Lampman5,6, Atieh Pajouhi7, Patricia J Erwin8, John Matulis7, Muhamad Elrashidi7, Joseph Darcel9, Mouaz Alsawas4, Zhen Wang4, Nilay D Shah5,6, M Hassan Murad4, Bjorg Thorsteinsdottir5,6,10.   

Abstract

INTRODUCTION: Chronic kidney disease (CKD) is widely prevalent, associated with morbidity and mortality, but may be lessened with timely implementation of evidence-based strategies including blood pressure (BP) control. Nonetheless, an evidence-practice gap persists. We synthesize the evidence for clinician-facing interventions to improve hypertension management in CKD patients in primary care.
METHODS: Electronic databases and related publications were queried for relevant studies. We used a conceptual model to address heterogeneity of interventions. We conducted a quantitative synthesis of interventions on blood pressure (BP) outcomes and a narrative synthesis of other CKD relevant clinical outcomes. Planned subgroup analyses were performed by (1) study design (randomized controlled trials (RCTs) or nonrandomized studies (NRS)); (2) intervention type (guideline-concordant decision support, shared care, pharmacist-facing); and (3) use of behavioral/implementation theory.
RESULTS: Of 2704 manuscripts screened, 73 underwent full-text review; 22 met inclusion criteria. BP target achievement was reported in 15 and systolic BP reduction in 6 studies. Among RCTs, all interventions had a significant effect on BP control, (pooled OR 1.21; 95% CI 1.07 to 1.38). Subgroup analysis by intervention type showed significant effects for guideline-concordant decision support (pooled OR 1.19; 95% CI 1.12 to 1.27) but not shared care (pooled OR 1.71; 95% CI 0.96 to 3.03) or pharmacist-facing interventions (pooled OR 1.04; 95% CI 0.82 to 1.34). Subgroup analysis finding was replicated with pooling of RCTs and NRS. The five contributing studies showed large and significant reduction in systolic BP (pooled WMD - 3.86; 95% CI - 7.2 to - 0.55). Use of a behavioral/implementation theory had no impact, while RCTs showed smaller effect sizes than NRS. DISCUSSION: Process-oriented implementation strategies used with guideline-concordant decision support was a promising implementation approach. Better reporting guidelines on implementation would enable more useful synthesis of the efficacy of CKD clinical interventions integrated into primary care. PROSPERO REGISTRATION NUMBER: CRD42018102441.

Entities:  

Keywords:  blood pressure control; chronic kidney disease; guideline implementation; implementation strategies; primary care practitioner interventions; systematic review

Mesh:

Year:  2020        PMID: 33107008      PMCID: PMC7652970          DOI: 10.1007/s11606-020-06103-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  63 in total

1.  Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program.

Authors:  Bharati Bhardwaja; Nikki M Carroll; Marsha A Raebel; Elizabeth A Chester; Eli J Korner; Bob E Rocho; David W Brand; David J Magid
Journal:  Pharmacotherapy       Date:  2011-04       Impact factor: 4.705

2.  Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.

Authors:  Andrew S Levey; Anton C Schoolwerth; Nilka Ríos Burrows; Desmond E Williams; Karma Rabon Stith; William McClellan
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

3.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

4.  Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program.

Authors:  Ayub Akbari; Peter J Swedko; Heather D Clark; William Hogg; Jacques Lemelin; Peter Magner; Lisa Moore; Daylily Ooi
Journal:  Arch Intern Med       Date:  2004-09-13

5.  The Adaptome: Advancing the Science of Intervention Adaptation.

Authors:  David A Chambers; Wynne E Norton
Journal:  Am J Prev Med       Date:  2016-06-28       Impact factor: 5.043

6.  Intensification of blood pressure treatment in Pasifika people with type 2 diabetes and renal disease: a cohort study in primary care.

Authors:  Jasmine Tan; Fifita McCready; Fiona Noovao; Oketi Tepueluelu; John Collins; Tim Cundy
Journal:  N Z Med J       Date:  2014-10-17

7.  Impact of a chronic kidney disease registry and provider education on guideline adherence--a cluster randomized controlled trial.

Authors:  Paul E Drawz; R Tyler Miller; Simran Singh; Brook Watts; Elizabeth Kern
Journal:  BMC Med Inform Decis Mak       Date:  2012-07-05       Impact factor: 2.796

8.  Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment--a comparative study.

Authors:  M Angeles Via-Sosa; Natali Lopes; Marian March
Journal:  BMC Fam Pract       Date:  2013-07-13       Impact factor: 2.497

9.  Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results.

Authors:  Simon de Lusignan; Simon de Lusignana; Hugh Gallagher; Simon Jones; Tom Chan; Jeremy van Vlymen; Aumran Tahir; Nicola Thomas; Neerja Jain; Olga Dmitrieva; Imran Rafi; Andrew McGovern; Kevin Harris
Journal:  Kidney Int       Date:  2013-03-27       Impact factor: 10.612

10.  Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.

Authors:  Kunihiro Yamagata; Hirofumi Makino; Kunitoshi Iseki; Sadayoshi Ito; Kenjiro Kimura; Eiji Kusano; Takanori Shibata; Kimio Tomita; Ichiei Narita; Tomoya Nishino; Yoshihide Fujigaki; Tetsuya Mitarai; Tsuyoshi Watanabe; Takashi Wada; Teiji Nakamura; Seiichi Matsuo
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more
  4 in total

1.  Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up.

Authors:  Dragan Kalinić; Ranko Škrbić; Duško Vulić; Nataša Stojaković; Svjetlana Stoisavljević-Šatara; Miloš P Stojiljković; Vanda Marković-Peković; Ana Golić Jelić; Nataša Pilipović-Broćeta; Nathan D Wong; Brian Godman
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Data-driven approach to implementation mapping for the selection of implementation strategies: a case example for risk-aligned bladder cancer surveillance.

Authors:  Florian R Schroeck; A Aziz Ould Ismail; David A Haggstrom; Steven L Sanchez; DeRon R Walker; Lisa Zubkoff
Journal:  Implement Sci       Date:  2022-09-01       Impact factor: 7.960

Review 3.  The Effectiveness of Pharmacist Interventions in the Management of Patient with Renal Failure: A Systematic Review and Meta-Analysis.

Authors:  Magdalena Jasińska-Stroschein
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

4.  Responding to the Call: a New JGIM Area of Emphasis for Implementation and Quality Improvement Sciences.

Authors:  Christian D Helfrich; Lucy A Savitz
Journal:  J Gen Intern Med       Date:  2020-11       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.